MYC and breast cancer: In breast cancer cells, elevated intracellular lactate levels cause H3 K18 la enrichment in the − 70 to + 3 promoter area, which increases c-Myc expression; this, in turn, controls SRSF10 to affect alternative splicing of MDM4 and Bcl-x [69].